Source: PR Newswire

Press Release: Corvidia : Corvidia Therapeutics to Present New Data at ASN Kidney Week 2019

WALTHAM, Mass., Nov. 6, 2019 /PRNewswire/ -- Corvidia Therapeutics, a clinical stage company focused on the research, development and commercialization of transformative therapies in cardio-renal disease, will deliver two key presentations at the American Society of Nephrology's annual...

Read full article »
Est. Annual Revenue
$5.0-25M
Est. Employees
25-100
Marc De Garidel's photo - CEO of Corvidia

CEO

Marc De Garidel

CEO Approval Rating

76/100

Read more